KEGG   PATHWAY: rno05200
Entry
rno05200                    Pathway                                
Name
Pathways in cancer - Rattus norvegicus (rat)
Class
Human Diseases; Cancer: overview
Pathway map
rno05200  Pathways in cancer
rno05200

Organism
Rattus norvegicus (rat) [GN:rno]
Gene
100360342  Msh6; DNA mismatch repair protein Msh6 [KO:K08737]
100360552  Fzd7; frizzled-7 precursor [KO:K02432]
100362121  Ddb2; DNA damage-binding protein 2 [KO:K10140]
100362620  Cks2l1; cyclin-dependent kinases regulatory subunit 2-like [KO:K02219]
100911464  [KO:K23790]
100911527  Ifna4l1; interferon alpha-11-like [KO:K05414]
100912314  [KO:K05414]
100912356  [KO:K05414]
103691088  Elocl1; elongin-C-like [KO:K03872]
103691134  Flt3lg; fms-related tyrosine kinase 3 ligand precursor [KO:K05454]
103691373  Frat1; proto-oncogene FRAT1 [KO:K03069]
114103  Il5ra; interleukin-5 receptor subunit alpha precursor [KO:K05067]
114110  Flt4; vascular endothelial growth factor receptor 3 precursor [KO:K05097] [EC:2.7.10.1]
114111  Vegfc; vascular endothelial growth factor C precursor [KO:K05449]
114117  Gng3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
114118  Gng4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
114119  Gng10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
114120  Gng12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
114125  Dll3; delta-like protein 3 precursor [KO:K06051]
114483  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
114486  Braf; serine/threonine-protein kinase B-raf isoform X2 [KO:K04365] [EC:2.7.11.1]
114487  Wnt2; protein Wnt-2 precursor [KO:K00182]
114494  Ccna2; cyclin-A2 [KO:K06627]
114517  Itga6; integrin alpha-6 precursor [KO:K06485]
114846  Gsto1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
114850  Wnt7a; protein Wnt-7a precursor [KO:K00572]
114851  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
116465  Ifngr1; interferon gamma receptor 1 precursor [KO:K05132]
116466  Wnt2b; protein Wnt-2b [KO:K00182]
116498  F2rl3; proteinase-activated receptor 4 [KO:K04236]
116499  Fgf4; fibroblast growth factor 4 precursor [KO:K04358]
116502  Bak1; bcl-2 homologous antagonist/killer [KO:K14021]
116546  Ralb; ras-related protein Ral-B [KO:K07835]
116553  Il13; interleukin-13 precursor [KO:K05435]
116554  Mapk8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
116562  Il2; interleukin-2 precursor [KO:K05429]
116590  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
116744  Lpar1; lysophosphatidic acid receptor 1 [KO:K04289]
117036  Lamc1; laminin subunit gamma-1 precursor [KO:K05635]
117273  Rhoa; transforming protein RhoA [KO:K04513]
117519  Keap1; kelch-like ECH-associated protein 1 [KO:K10456]
117557  Tpm3; tropomyosin alpha-3 chain isoform Tpm3.3cy [KO:K09290]
120097475  [KO:K03872]
120099279  [KO:K03872]
120099910  [KO:K08738]
120101893  Elob-ps3; elongin-B-like [KO:K03873]
120101894  Elob-ps13; elongin-B-like [KO:K03873]
120101895  Elob-ps5; elongin-B-like [KO:K03873]
120101896  Elob-ps7; elongin-B-like [KO:K03873]
120101899  Elob-ps15; elongin-B-like [KO:K03873]
120102505  [KO:K02219]
134482328  [KO:K03872]
134482331  [KO:K03872]
134482335  [KO:K03872]
134482343  [KO:K03872]
134482344  [KO:K03872]
134482347  [KO:K03872]
134482351  [KO:K03872]
134482354  [KO:K03872]
134482356  [KO:K03872]
134482358  [KO:K03872]
134482362  [KO:K03872]
134482363  [KO:K03872]
134482473  [KO:K03872]
134482479  [KO:K03872]
134482480  [KO:K03872]
134482481  [KO:K03872]
134482484  [KO:K03872]
134482485  [KO:K03872]
134482488  [KO:K03872]
134482489  [KO:K03872]
134482563  [KO:K03872]
134484121  [KO:K00922] [EC:2.7.1.153]
134486081  [KO:K03873]
134486082  [KO:K03873]
134486083  [KO:K03873]
134486084  [KO:K03873]
134486085  [KO:K03873]
134487075  [KO:K05414]
134487077  [KO:K05414]
140433  Lama5; laminin subunit alpha-5 precursor [KO:K06240]
140584  Wnt11; protein Wnt-11 [KO:K01384]
140588  Gli3; transcriptional activator GLI3 [KO:K06230]
140589  Gli1; zinc finger protein GLI1 [KO:K16797]
140635  Flt3; receptor-type tyrosine-protein kinase FLT3 precursor [KO:K05092] [EC:2.7.10.1]
140924  Il2rg; cytokine receptor common subunit gamma precursor [KO:K05070]
155140  Il23a; interleukin-23 subunit alpha precursor [KO:K05426]
155430  Hey2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
155437  Hey1; hairy/enhancer-of-split related with YRPW motif protein 1 [KO:K09091]
161452  Lef1; lymphoid enhancer-binding factor 1 [KO:K04492]
170579  Fgf22; fibroblast growth factor 22 precursor [KO:K04358]
170580  Fgf21; fibroblast growth factor 21 precursor [KO:K22429]
170582  Fgf19; fibroblast growth factor 19 precursor [KO:K22603]
170583  Fgf23; fibroblast growth factor 23 precursor [KO:K22428]
170633  Fgf3; fibroblast growth factor 3 precursor [KO:K04358]
170668  Rasgrp4; RAS guanyl-releasing protein 4 [KO:K12363]
170700  Fgf6; fibroblast growth factor 6 [KO:K04358]
170851  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
170911  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
170915  Ep300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
170921  Itga2; integrin alpha-2 precursor [KO:K06481]
171081  Csf2rb; cytokine receptor common subunit beta precursor [KO:K04738]
171140  Camk2g; calcium/calmodulin-dependent protein kinase type II subunit gamma [KO:K04515] [EC:2.7.11.17]
171333  Il12rb1; interleukin-12 receptor subunit beta-1 precursor [KO:K05063]
171334  Il12rb2; interleukin-12 receptor subunit beta-2 precursor [KO:K05064]
171341  Mgst1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
171525  Polk; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
192362  Lamc2; laminin subunit gamma-2 precursor [KO:K06246]
24179  Agt; angiotensinogen precursor [KO:K09821]
24180  Agtr1a; type-1 angiotensin II receptor A [KO:K04166]
24185  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
24205  Apc; adenomatous polyposis coli protein [KO:K02085]
24208  Ar; androgen receptor [KO:K08557]
24224  Bcl2; apoptosis regulator Bcl-2 [KO:K02161]
24242  Calm1; calmodulin-1 [KO:K02183]
24244  Calm3; calmodulin-3 [KO:K02183]
24245  Camk2b; calcium/calmodulin-dependent protein kinase type II subunit beta isoform 2 [KO:K04515] [EC:2.7.11.17]
24246  Camk2d; calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
24252  Cebpa; CCAAT/enhancer-binding protein alpha isoform a [KO:K09055]
24314  Nqo1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
24323  Edn1; endothelin-1 preproprotein [KO:K16366]
24326  Ednra; endothelin-1 receptor precursor [KO:K04197]
24329  Egfr; epidermal growth factor receptor isoform 2 precursor [KO:K04361] [EC:2.7.10.1]
24335  Epo; erythropoietin precursor [KO:K05437]
24336  Epor; erythropoietin receptor precursor [KO:K05079]
24337  Erbb2; receptor tyrosine-protein kinase erbB-2 precursor [KO:K05083] [EC:2.7.10.1]
24356  Ets1; protein C-ets-1 [KO:K02678]
24368  Fh; fumarate hydratase, mitochondrial precursor [KO:K01679] [EC:4.2.1.2]
24400  Gnb1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
24421  Gsta1; glutathione S-transferase alpha-3 [KO:K00799] [EC:2.5.1.18]
24422  Gsta2; glutathione S-transferase alpha-1 [KO:K00799] [EC:2.5.1.18]
24423  Gstm1; glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
24424  Gstm2; glutathione S-transferase Mu 2 [KO:K00799] [EC:2.5.1.18]
24426  Gstp1; glutathione S-transferase P [KO:K23790]
24446  Hgf; hepatocyte growth factor preproprotein [KO:K05460]
24451  Hmox1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
24482  Igf1; insulin-like growth factor I isoform d preproprotein [KO:K05459]
24483  Igf2; insulin-like growth factor II isoform 2 preproprotein [KO:K13769]
24495  Il3; interleukin-3 precursor [KO:K04736]
24497  Il5; interleukin-5 precursor [KO:K05428]
24498  Il6; interleukin-6 precursor [KO:K05405]
24499  Il6r; interleukin-6 receptor subunit alpha precursor [KO:K05055]
24511  Itgb1; integrin beta-1 precursor [KO:K05719]
24514  Jak2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
24516  Jun; transcription factor Jun [KO:K04448]
24525  Kras; GTPase KRas [KO:K07827]
24553  Met; hepatocyte growth factor receptor precursor [KO:K05099] [EC:2.7.10.1]
24577  Myc; myc proto-oncogene protein [KO:K04377]
245986  Gng8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
24599  Nos2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
24605  Nras; GTPase NRas [KO:K07828]
246097  Fas; tumor necrosis factor receptor superfamily member 6 precursor [KO:K04390]
246144  Il3ra; interleukin-3 receptor subunit alpha precursor [KO:K04737]
24628  Pdgfb; platelet-derived growth factor subunit B precursor [KO:K17386]
24629  Pdgfrb; platelet-derived growth factor receptor beta precursor [KO:K05089] [EC:2.7.10.1]
24649  Pim1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
24654  Plcb1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
24680  Prkca; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
24681  Prkcg; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
24703  Raf1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
24705  Rara; retinoic acid receptor alpha [KO:K08527]
24706  Rarb; retinoic acid receptor beta [KO:K08528]
24708  Rb1; retinoblastoma-associated protein [KO:K06618]
24716  Ret; proto-oncogene tyrosine-protein kinase receptor Ret isoform a precursor [KO:K05126] [EC:2.7.10.1]
24772  Cxcl12; stromal cell-derived factor 1 isoform beta precursor [KO:K10031]
24778  Slc2a1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
24790  Sp1; transcription factor Sp1 [KO:K04684]
24827  Tgfa; protransforming growth factor alpha preproprotein [KO:K08774]
24842  Tp53; cellular tumor antigen p53 [KO:K04451]
24874  Vhl; von Hippel-Lindau disease tumor suppressor [KO:K03871]
24881  Wnt1; proto-oncogene Wnt-1 precursor [KO:K03209]
24882  Wnt3; proto-oncogene Wnt-3 [KO:K00312]
24887  Bax; apoptosis regulator BAX [KO:K02159]
24888  Bcl2l1; bcl-2-like protein 1 isoform 2 [KO:K04570]
24890  Esr1; estrogen receptor [KO:K08550]
24896  Gnas; SCG6 (secretogranin VI) isoform SCG6 precursor [KO:K04632]
24903  Kng2; T-kininogen 1 precursor [KO:K03898]
24918  Stat5a; signal transducer and activator of transcription 5A [KO:K11223]
24929  Ptger3; prostaglandin E2 receptor EP3 subtype [KO:K04260]
25022  Fgfr2; fibroblast growth factor receptor 2 isoform b [KO:K05093] [EC:2.7.10.1]
25023  Prkcb; protein kinase C beta type isoform 2 [KO:K19662] [EC:2.7.11.13]
25031  Plcb4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 [KO:K05858] [EC:3.1.4.11]
25084  Il4r; interleukin-4 receptor subunit alpha precursor [KO:K05071]
25087  Kng2l1; kininogen-1 isoform 1 precursor [KO:K03898]
25094  Mitf; microphthalmia-associated transcription factor isoform 1 [KO:K09455]
25096  Pld1; phospholipase D1 isoform 2 [KO:K01115] [EC:3.1.4.4]
25097  Pld2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
25112  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
25114  Fgfr4; fibroblast growth factor receptor 4 precursor [KO:K05095] [EC:2.7.10.1]
25124  Stat1; signal transducer and activator of transcription 1-alpha/beta isoform beta [KO:K11220]
25125  Stat3; signal transducer and activator of transcription 3 [KO:K04692]
25126  Stat5b; signal transducer and activator of transcription 5B [KO:K11224]
25149  Esr2; estrogen receptor beta [KO:K08551]
25163  Cdkn2a; cyclin-dependent kinase inhibitor 2A [KO:K06621]
25164  Cdkn2b; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
25193  Ccnd3; G1/S-specific cyclin-D3 [KO:K10152]
25205  Il6st; interleukin-6 receptor subunit beta precursor [KO:K05060]
25233  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
25242  Arnt; aryl hydrocarbon receptor nuclear translocator isoform 1 [KO:K09097]
25243  Arnt2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]
25245  Bdkrb2; B2 bradykinin receptor isoform 2 [KO:K03916]
25260  Gstt1; glutathione S-transferase theta-1 [KO:K00799] [EC:2.5.1.18]
25266  Pdgfa; platelet-derived growth factor subunit A precursor [KO:K04359]
25267  Pdgfra; platelet-derived growth factor receptor alpha precursor [KO:K04363] [EC:2.7.10.1]
25271  Rxra; retinoic acid receptor RXR-alpha [KO:K08524]
25272  Mapk10; mitogen-activated protein kinase 10 isoform 2 [KO:K04440] [EC:2.7.11.24]
25273  Smo; protein smoothened precursor [KO:K06226]
25289  Adcy6; adenylate cyclase type 6 isoform 2 [KO:K08046] [EC:4.6.1.1]
25296  Bmp4; bone morphogenetic protein 4 precursor [KO:K04662]
252963  Il13ra1; interleukin-13 receptor subunit alpha-1 precursor [KO:K05076]
25309  Cycs; cytochrome c, somatic [KO:K08738]
25310  Cyct; cytochrome c, testis-specific [KO:K08738]
25311  Dcc; netrin receptor DCC precursor [KO:K06765]
25313  Egf; pro-epidermal growth factor precursor [KO:K04357]
25317  Fgf1; fibroblast growth factor 1 [KO:K18496]
25326  Jak3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
25385  Faslg; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
25400  Camk2a; calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
25402  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
25439  F2r; proteinase-activated receptor 1 precursor [KO:K03914]
25443  Fgf10; fibroblast growth factor 10 precursor [KO:K04358]
25444  Fgf9; fibroblast growth factor 9 [KO:K04358]
25473  Lamb2; laminin subunit beta-2 precursor [KO:K06243]
25493  Nfkbia; NF-kappa-B inhibitor alpha [KO:K04734]
25496  Notch1; neurogenic locus notch homolog protein 1 precursor [KO:K02599]
25513  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649]
25537  Rock2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.39]
25614  Ptk2; focal adhesion kinase 1 [KO:K05725] [EC:2.7.10.2]
25631  Smad3; mothers against decapentaplegic homolog 3 [KO:K23605]
25636  Prkaca; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
25637  Ptger1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
25643  Gnai3; guanine nucleotide-binding protein G(i) subunit alpha-3 [KO:K04630]
25647  Il7; interleukin-7 precursor [KO:K05431]
25661  Fn1; fibronectin precursor [KO:K05717]
25664  Pparg; peroxisome proliferator-activated receptor gamma isoform 1 [KO:K08530]
25670  Il15; interleukin-15 preproprotein [KO:K05433]
25682  Ppard; peroxisome proliferator-activated receptor delta [KO:K04504]
25686  Gnai1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
25704  Il2ra; interleukin-2 receptor subunit alpha precursor [KO:K05068]
25712  Ifng; interferon gamma precursor [KO:K04687]
25717  Tgfb3; transforming growth factor beta-3 proprotein preproprotein [KO:K13377]
25718  Igf1r; insulin-like growth factor 1 receptor isoform 2 precursor [KO:K05087] [EC:2.7.10.1]
25729  Ccne1; G1/S-specific cyclin-E1 [KO:K06626]
25738  Plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
25746  Il2rb; interleukin-2 receptor subunit beta precursor [KO:K05069]
266608  Fzd9; frizzled-9 precursor [KO:K02842]
266610  Fadd; FAS-associated death domain protein [KO:K02373]
266715  Fzd3; frizzled-3 precursor [KO:K02329]
266802  Alk; ALK tyrosine kinase receptor precursor [KO:K05119] [EC:2.7.10.1]
282581  Fzd6; frizzled-6 precursor [KO:K02376]
282582  Wnt5b; protein Wnt-5b precursor [KO:K00444]
287280  Skp1; S-phase kinase-associated protein 1 [KO:K03094]
287287  Il4; interleukin-4 precursor [KO:K05430]
287357  Wnt9a; protein Wnt-9a precursor [KO:K01064]
287942  Crkl; crk-like protein [KO:K04438]
288001  Kng1; T-kininogen 2 precursor [KO:K03898]
288264  Ifnar1; interferon alpha/beta receptor 1 isoform 1 precursor [KO:K05130]
288774  Stat2; signal transducer and activator of transcription 2 [KO:K11221]
289197  Mgst3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
290019  Cycsl3; cytochrome c, somatic-like [KO:K08738]
290537  Appl1; DCC-interacting protein 13-alpha [KO:K08733]
290905  Col4a1; collagen alpha-1(IV) chain precursor [KO:K06237]
291005  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
291105  E2f3; transcription factor E2F3 [KO:K06620]
29134  Axin2; axin-2 [KO:K04385]
29146  Jag1; protein jagged-1 precursor [KO:K06052]
29147  Jag2; protein jagged-2 isoform 2 [KO:K21635]
291678  Wnt8a; protein Wnt-8a precursor [KO:K00714]
291936  Hhip; hedgehog-interacting protein precursor [KO:K06231]
29241  Adcy8; adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
29251  F2; prothrombin precursor [KO:K01313] [EC:3.4.21.5]
293047  Kif7; kinesin-like protein KIF7 isoform X2 [KO:K18806]
29322  Plcb3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
29337  Plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
29348  Fgf7; fibroblast growth factor 7 precursor [KO:K04358]
29349  Fgf8; fibroblast growth factor 8 isoform 1 precursor [KO:K04358]
293508  Prkacb; cAMP-dependent protein kinase catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
29357  Smad2; mothers against decapentaplegic homolog 2 [KO:K04500]
293621  Hras; GTPase HRas [KO:K02833]
293649  Lrp5; low-density lipoprotein receptor-related protein 5 precursor [KO:K03068]
293656  Gstp3; Glutathione S-transferase P-like isoform 2 [KO:K23790]
29368  Fgf17; fibroblast growth factor 17 isoform 1 precursor [KO:K04358]
29369  Fgf18; fibroblast growth factor 18 precursor [KO:K04358]
29373  Bmp2; bone morphogenetic protein 2 precursor [KO:K21283]
29382  Ctbp1; C-terminal-binding protein 1 [KO:K04496] [EC:1.1.1.428]
293990  Wnt8b; protein Wnt-8b precursor [KO:K00714]
29414  Akt3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
29434  Rasgrp1; RAS guanyl-releasing protein 1 [KO:K04350]
29452  Epas1; endothelial PAS domain-containing protein 1 [KO:K09095]
294790  Skp2; S-phase kinase-associated protein 2 [KO:K03875]
294797  Il7r; interleukin-7 receptor subunit alpha precursor [KO:K05072]
29487  Gstt2; glutathione S-transferase theta-2 [KO:K00799] [EC:2.5.1.18]
29492  Notch2; neurogenic locus notch homolog protein 2 precursor [KO:K20994]
294924  Mecom; histone-lysine N-methyltransferase MECOM [KO:K04462] [EC:2.1.1.367]
294962  Gnb4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
29499  Shh; sonic hedgehog protein precursor [KO:K11988]
295037  Mgst2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
295052  Ccna1; cyclin-A1 [KO:K06627]
29527  Ptgs2; prostaglandin G/H synthase 2 precursor [KO:K11987] [EC:1.14.99.1]
295362  Gstm6l; glutathione S-transferase, mu 6-like [KO:K00799] [EC:2.5.1.18]
29560  Hif1a; hypoxia-inducible factor 1-alpha [KO:K08268]
29577  Hes1; transcription factor HES-1 [KO:K06054]
29591  Tgfbr1; TGF-beta receptor type-1 precursor [KO:K04674] [EC:2.7.11.30]
29622  Ralgds; ral guanine nucleotide dissociation stimulator isoform 1 [KO:K08732]
296456  Itgav; integrin alpha-V isoform 1 precursor [KO:K06487]
296468  Birc7; baculoviral IAP repeat-containing protein 7 [KO:K16061]
297173  RSA-14-44; ras homolog gene family, member A [KO:K04513]
297357  Ctnna2; catenin alpha-2 isoform 1 [KO:K05691]
29741  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
297437  Txnrd3; thioredoxin reductase 3 isoform 2 [KO:K22182] [EC:1.8.1.9]
297893  Hdac1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
298205  Ifna4; interferon, alpha 4 precursor [KO:K05414]
298210  Ifna5; interferon alpha-1 precursor [KO:K05414]
298213  Ifna2; interferon alpha family, gene 2 precursor [KO:K05414]
298518  Csf3r; granulocyte colony-stimulating factor receptor precursor [KO:K05061]
298941  Lamb1; laminin subunit beta-1 precursor [KO:K05636]
299331  Hsp90aa1; heat shock protein HSP 90-alpha [KO:K04079]
299611  Apc2; adenomatous polyposis coli protein 2 [KO:K02085]
299626  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
300084  Rbx1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
300338  Mmp1b; interstitial collagenase B [KO:K01388] [EC:3.4.24.7]
300339  Mmp1; interstitial collagenase precursor [KO:K01388] [EC:3.4.24.7]
300799  Dapk2; death-associated protein kinase 2 isoform 1 [KO:K08803] [EC:2.7.11.1]
300850  Gsta4; glutathione S-transferase alpha-4 [KO:K00799] [EC:2.5.1.18]
301252  Hsp90ab1; heat shock protein HSP 90-beta [KO:K04079]
301965  Tert; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]
302378  Lpar4; lysophosphatidic acid receptor 4 [KO:K04275]
302950  Adcy9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
303181  Wnt3a; protein Wnt-3a precursor [KO:K00312]
303251  Dvl2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
303285  Traf4; TNF receptor-associated factor 4 [KO:K09848]
303586  Wnt9b; protein Wnt-9b precursor [KO:K01064]
303634  Gna13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
303811  Dvl3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
304729  Gli2; zinc finger protein GLI2 [KO:K16798]
304862  Tpr; nucleoprotein TPR [KO:K09291]
305078  Lamb3; laminin subunit beta-3 precursor [KO:K06244]
305509  Adcy1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
305999  Nkx3-1; homeobox protein Nkx-3.1 [KO:K09348]
306628  Col4a2; collagen alpha-2(IV) chain precursor [KO:K06237]
306722  Dapk1; death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
307100  Calml3; calmodulin-like protein 3 [KO:K02183]
307403  Csf1r; macrophage colony-stimulating factor 1 receptor precursor [KO:K05090] [EC:2.7.10.1]
307505  Ctnna1; catenin alpha-1 [KO:K05691]
307582  Lama3; laminin subunit alpha-3 isoform B precursor [KO:K06240]
308457  Egln2; prolyl hydroxylase EGLN2 [KO:K09592] [EC:1.14.11.29]
308692  Peg12; paternally expressed 12 [KO:K03069]
308913  Egln1; egl nine homolog 1 [KO:K09592] [EC:1.14.11.29]
309165  Rela; transcription factor p65 [KO:K04735]
309295  Ikbkg; NF-kappa-B essential modulator [KO:K07210]
309361  Chuk; inhibitor of nuclear factor kappa-B kinase subunit alpha [KO:K04467] [EC:2.7.11.10]
309368  Lama2; laminin subunit alpha-2 precursor [KO:K05637]
309452  Nfkb2; nuclear factor NF-kappa-B p100 subunit [KO:K04469]
309465  Gsto2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
309696  Bcr; breakpoint cluster region protein [KO:K08878] [EC:2.7.11.1]
309816  Lama4; laminin subunit alpha-4 precursor [KO:K06241]
310999  Plekhg5; pleckstrin homology domain-containing family G member 5 isoform 3 [KO:K19464]
311245  Traf6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
311332  Dll4; delta-like protein 4 precursor [KO:K06051]
311622  Stk4; serine/threonine-protein kinase 4 [KO:K04411]
311786  Traf2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
311860  Abl1; tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
311862  Lamc3; laminin subunit gamma-3 precursor [KO:K06247]
312451  Tcf7l1; transcription factor 7-like 1 [KO:K04490]
312781  Lrp6; low-density lipoprotein receptor-related protein 6 isoform 2 precursor [KO:K03068]
313575  Heyl; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
313666  Zbtb17; zinc finger and BTB domain-containing protein 17 [KO:K10500]
313845  Sos1; son of sevenless homolog 1 [KO:K03099]
313861  Eml4; echinoderm microtubule-associated protein-like 4 [KO:K15420]
313874  Rasgrp3; ras guanyl-releasing protein 3 [KO:K12362]
313929  Ncoa1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]
314322  Fos; protein c-Fos [KO:K04379]
314384  Rps6ka5; ribosomal protein S6 kinase alpha-5 [KO:K04445] [EC:2.7.11.1]
314436  Elk1; ETS domain-containing protein Elk-1 [KO:K04375]
314856  Mdm2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
315196  Wnt7b; protein Wnt-7b isoform 1 [KO:K00572]
315294  Wnt10b; protein Wnt-10b precursor [KO:K01357]
315713  Pml; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]
316526  Wnt6; protein Wnt-6 precursor [KO:K00445]
316527  Wnt10a; protein Wnt-10a precursor [KO:K01357]
316758  Lama1; laminin subunit alpha-1 precursor [KO:K05637]
317366  Pim2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
317673  Bbc3; bcl-2-binding component 3 [KO:K10132]
317674  Fzd5; frizzled-5 precursor [KO:K02375]
353227  Zbtb16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
360254  Brca2; breast cancer type 2 susceptibility protein homolog [KO:K08775]
360457  Vegfd; vascular endothelial growth factor D precursor [KO:K05449]
360606  Itga3; integrin alpha-3 isoform 1 [KO:K06482]
360697  Ifngr2; interferon gamma receptor 2 precursor [KO:K05133]
360709  Tfg; protein TFG [KO:K09292]
361258  Cul2; cullin-2 [KO:K03870]
361696  Rps6kb2; ribosomal protein S6 kinase beta-2 [KO:K04688] [EC:2.7.11.1]
361714  Rasgrp2; RAS guanyl-releasing protein 2 [KO:K12361]
361769  Sufu; suppressor of fused homolog [KO:K06229]
361801  Rxrb; retinoic acid receptor RXR-beta [KO:K08525]
361839  Ctnna3; catenin alpha-3 [KO:K05691]
362356  Cul1; cullin-1 [KO:K03347]
362485  Ccne2; G1/S-specific cyclin-E2 [KO:K06626]
362489  Runx1t1; protein CBFA2T1 [KO:K10053]
362788  Traf3; TNF receptor-associated factor 3 [KO:K03174]
362817  Cdk2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
362862  Hsp90b1; endoplasmin precursor [KO:K09487]
362896  Stat6; signal transducer and activator of transcription 6 [KO:K11225]
363140  Rassf1; ras association domain-containing protein 1 isoform 2 [KO:K09850]
363205  Gsta3l1; glutathione S-transferase [KO:K00799] [EC:2.5.1.18]
363265  Col4a3; collagen alpha-3(IV) chain precursor [KO:K06237]
363457  Col4a5; collagen alpha-5(IV) chain precursor [KO:K06237]
363458  Col4a6; collagen type IV alpha 6 chain precursor [KO:K06237]
363595  Tcf7; transcription factor 7 [KO:K02620]
363875  Rac1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
363913  Fzd10; frizzled-10 precursor [KO:K02842]
364754  Fzd8; frizzled-8 precursor [KO:K02375]
364774  Calml5; calmodulin-like protein 5 [KO:K02183]
366126  Spi1; transcription factor PU.1 [KO:K09438]
366508  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
366957  Rac2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
367072  Arhgef12; rho guanine nucleotide exchange factor 12 [KO:K07532]
367149  Bax-ps1; apoptosis regulator BAX-like [KO:K02159]
367264  Stat4; signal transducer and activator of transcription 4 [KO:K11222]
367858  Hrasl1; HRas proto-oncogene, GTPase like 1 [KO:K02833]
378461  Terc; telomerase RNA component [KO:K22183]
399489  E2f1; transcription factor E2F1 [KO:K17454]
406162  Notch4; neurogenic locus notch homolog protein 4 precursor [KO:K20996]
492821  Pmaip1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
494499  Gsta5; glutathione S-transferase alpha-2 [KO:K00799] [EC:2.5.1.18]
494500  Gsta3; glutathione S-transferase alpha-5 isoform 1 [KO:K00799] [EC:2.5.1.18]
498340  Mgst3l1; glutathione S-transferase 3, mitochondrial-like [KO:K00799] [EC:2.5.1.18]
498609  Lpar2; lysophosphatidic acid receptor 2 [KO:K04291]
498709  Cks2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
499422  Gstt3; glutathione S-transferase, theta 3 [KO:K00799] [EC:2.5.1.18]
499505  Msh3; DNA mismatch repair protein Msh3 [KO:K08736]
499655  Cks1b; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
499688  Gstm6; glutathione S-transferase Mu 6 [KO:K00799] [EC:2.5.1.18]
499689  Gstm4; glutathione S-transferase Mu 4 [KO:K00799] [EC:2.5.1.18]
499870  Rad51; DNA repair protein RAD51 homolog 1 [KO:K04482]
500047  Wnt16; protein Wnt-16 precursor [KO:K01558]
500317  Lpar5; lysophosphatidic acid receptor 5 [KO:K08390]
500491  Ifna16l1; interferon, alpha 16-like 1 precursor [KO:K05414]
500985  Cbl; E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
501110  Gsta6; glutathione S-transferase A6 [KO:K00799] [EC:2.5.1.18]
502620  Elob-ps8; elongin-B-like [KO:K03873]
502959  Ifna1l1; similar to put. precursor MuIFN-alpha 5 precursor [KO:K05414]
502961  Ifna4l2; similar to Interferon alpha-1 precursor [KO:K05414]
50551  Txnrd2; thioredoxin reductase 2, mitochondrial precursor [KO:K22182] [EC:1.8.1.9]
50554  Smad4; mothers against decapentaplegic homolog 4 [KO:K04501]
50557  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
50658  Mapk9; mitogen-activated protein kinase 9 isoform 2 [KO:K04440] [EC:2.7.11.24]
50662  Runx1; runt-related transcription factor 1 [KO:K08367]
50663  Calm2; calmodulin-2 [KO:K02183]
50672  Ednrb; endothelin receptor type B precursor [KO:K04198]
50689  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
54223  Adcy4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
54244  Crebbp; histone lysine acetyltransferase CREBBP [KO:K04498] [EC:2.3.1.48]
54245  Crk; adapter molecule crk [KO:K04438]
54250  Fgf2; fibroblast growth factor 2 [KO:K18497]
54355  Rassf5; ras association domain-containing protein 5 [KO:K08015]
54702  Egln3; prolyl hydroxylase EGLN3 [KO:K09592] [EC:1.14.11.29]
56718  Mtor; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
56761  Notch3; neurogenic locus notch homolog protein 3 precursor [KO:K20995]
57298  Gstm3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
58819  Txnrd1; thioredoxin reductase 1, cytoplasmic isoform 1 [KO:K22182] [EC:1.8.1.9]
58868  Fzd1; frizzled-1 precursor [KO:K02432]
58918  Casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
58919  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
58960  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
58979  Gng7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
59086  Tgfb1; transforming growth factor beta-1 proprotein precursor [KO:K13375]
59109  Ntrk1; high affinity nerve growth factor receptor precursor [KO:K03176] [EC:2.7.10.1]
60323  Arhgef1; rho guanine nucleotide exchange factor 1 [KO:K12330]
60371  Birc2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
60427  Kitlg; kit ligand isoform 1 precursor [KO:K05461]
60449  Gnb3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
60464  Fgf16; fibroblast growth factor 16 [KO:K04358]
60628  Cxcr4; C-X-C chemokine receptor type 4 [KO:K04189]
60661  Max; protein max isoform 1 [KO:K04453]
60662  Fgf5; fibroblast growth factor 5 isoform 1 precursor [KO:K04358]
60664  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
619385  Ncoa4; nuclear receptor coactivator 4 [KO:K09289]
63879  Xiap; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
64026  Casp7; caspase-7 [KO:K04397] [EC:3.4.22.60]
64030  Kit; mast/stem cell growth factor receptor Kit precursor [KO:K05091] [EC:2.7.10.1]
64033  Ccnd2; G1/S-specific cyclin-D2 [KO:K10151]
64041  Birc5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
64044  Casp8; caspase-8 [KO:K04398] [EC:3.4.22.61]
64199  Gng11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
64352  Gstm5; glutathione S-transferase Mu 5 [KO:K00799] [EC:2.5.1.18]
64363  Araf; serine/threonine-protein kinase A-Raf isoform 1 [KO:K08845] [EC:2.7.11.1]
64391  Dapk3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
64465  Cdc42; cell division control protein 42 homolog [KO:K04393]
64508  Adcy3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
64512  Fzd2; frizzled-2 precursor [KO:K02235]
64525  Eloc; elongin-C [KO:K03872]
64532  Adcy5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
64546  Il12b; interleukin-12 subunit beta precursor [KO:K05425]
64547  Bcl2l11; bcl-2-like protein 11 [KO:K16341]
64558  Fzd4; frizzled-4 precursor [KO:K02354]
64566  Wnt5a; protein Wnt-5a precursor [KO:K00444]
64625  Bid; BH3-interacting domain death agonist [KO:K04726]
64639  Bad; bcl2-associated agonist of cell death [KO:K02158]
652957  Csf2ra; granulocyte-macrophage colony-stimulating factor receptor subunit alpha precursor [KO:K05066]
66017  Fgf20; fibroblast growth factor 20 [KO:K04358]
66025  Lpar3; lysophosphatidic acid receptor 3 [KO:K04294]
679110  Frat2; GSK-3-binding protein FRAT2 [KO:K03096]
679794  Cycsl1; cytochrome c, somatic-like [KO:K08738]
679869  Tcf7l2; transcription factor 7-like 2 [KO:K04491]
680149  Gngt1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
681162  Cks1l; CDC28 protein kinase regulatory subunit 1-like [KO:K02219]
681314  [KO:K02159]
684111  E2f2; transcription factor E2F2 isoform X2 [KO:K09389]
684173  Traf5; TNF receptor-associated factor 5 [KO:K09849]
685269  Itga2b; integrin alpha-IIb precursor [KO:K06476]
685451  Gng13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
685513  Gng14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
686326  Ifnar2; interferon alpha and beta receptor subunit 2 isoform 1 precursor [KO:K05131]
686922  Gstt4; glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
687813  Traf1; TNF receptor-associated factor 1 [KO:K03172]
688319  Rac3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
689932  Il23r; interleukin-23 receptor isoform X1 [KO:K05065]
690241  Elob-ps14; elongin-B-like [KO:K03873]
690369  Il15ra; interleukin-15 receptor subunit alpha precursor [KO:K05074]
690675  Cycsl2; cytochrome c, somatic-like [KO:K08738]
690825  Gngt2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
690894  Ifna1; interferon alpha family, gene 5 precursor [KO:K05414]
691155  Ccdc6; coiled-coil domain containing 6 [KO:K09288]
691455  Calml4; calmodulin-like protein 4 [KO:K02183]
691774  Lpar6; lysophosphatidic acid receptor 6 [KO:K04273]
78963  Apaf1; apoptotic protease-activating factor 1 [KO:K02084]
78966  Arhgef11; rho guanine nucleotide exchange factor 11 [KO:K12331]
78971  Birc3; baculoviral IAP repeat-containing protein 3 [KO:K16060]
79114  Fgfr1; fibroblast growth factor receptor 1 precursor [KO:K04362] [EC:2.7.10.1]
79218  Gng5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
79225  Hes5; transcription factor HES-5 [KO:K06055]
79257  Axin1; axin-1 [KO:K02157]
80850  Gng2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
81504  Grb2; growth factor receptor-bound protein 2 [KO:K04364]
81509  Bdkrb1; B1 bradykinin receptor [KO:K03915]
81636  Adcy2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
81638  Agtr1b; type-1 angiotensin II receptor B [KO:K04166]
81662  Gna11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
81663  Gna12; guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
81664  Gnai2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
81666  Gnaq; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
81667  Gnb2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
81679  Jup; junction plakoglobin [KO:K10056]
81685  Mlh1; DNA mismatch repair protein Mlh1 [KO:K08734]
81686  Mmp2; 72 kDa type IV collagenase precursor [KO:K01398] [EC:3.4.24.24]
81687  Mmp9; matrix metalloproteinase-9 precursor [KO:K01403] [EC:3.4.24.35]
81709  Msh2; DNA mismatch repair protein Msh2 [KO:K08735]
81717  Ctbp2; C-terminal-binding protein 2 [KO:K04496] [EC:1.1.1.428]
81736  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform 2 [KO:K02580]
81752  Ptger2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
81757  Rala; ras-related protein Ral-A [KO:K07834]
81762  Rock1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.39]
81807  Elob; elongin-B [KO:K03873]
81809  Tgfb2; transforming growth factor beta-2 proprotein precursor [KO:K13376]
81810  Tgfbr2; TGF-beta receptor type-2 precursor [KO:K04388] [EC:2.7.11.30]
81819  Pax8; paired box protein Pax-8 [KO:K09293]
81869  Gstm7; glutathione S-transferase Mu 7 [KO:K00799] [EC:2.5.1.18]
83502  Cdh1; cadherin-1 precursor [KO:K05689]
83571  Cdkn1b; cyclin-dependent kinase inhibitor 1B [KO:K06624]
83574  Rxrg; retinoic acid receptor RXR-gamma [KO:K08526]
83579  Gnb5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
83619  Nfe2l2; nuclear factor erythroid 2-related factor 2 isoform 2 [KO:K05638]
83721  Dvl1; segment polarity protein dishevelled homolog DVL-1 [KO:K02353]
83785  Vegfa; vascular endothelial growth factor A isoform 6 precursor [KO:K05448]
83840  Rps6kb1; ribosomal protein S6 kinase beta-1 [KO:K04688] [EC:2.7.11.1]
84010  Dll1; delta-like protein 1 precursor [KO:K06051]
84014  Ralbp1; ralA-binding protein 1 [KO:K08773]
84023  Ptger4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
84027  Gsk3b; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
84351  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
84353  Ctnnb1; catenin beta-1 [KO:K02105]
84405  Il12a; interleukin-12 subunit alpha precursor [KO:K05406]
84420  Adcy7; adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
84426  Wnt4; protein Wnt-4 precursor [KO:K00408]
84482  Foxo1; forkhead box protein O1 [KO:K07201]
84489  Fgfr3; fibroblast growth factor receptor 3 precursor [KO:K05094] [EC:2.7.10.1]
84576  Hdac1l; histone deacetylase 1-like [KO:K06067] [EC:3.5.1.98]
84577  Hdac2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
84584  Ncoa3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]
84598  Jak1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
85240  Plcb2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
85243  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
85384  Sos2; son of sevenless homolog 2 [KO:K03099]
89811  Vegfb; vascular endothelial growth factor B precursor [KO:K16858]
89830  Ptch1; protein patched homolog 1 isoform 2 [KO:K06225]
94201  Cdk4; cyclin-dependent kinase 4 isoform 1 [KO:K02089] [EC:2.7.11.22]
94203  Pgf; placenta growth factor precursor [KO:K16859]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
rno03320  PPAR signaling pathway
rno04010  MAPK signaling pathway
rno04020  Calcium signaling pathway
rno04024  cAMP signaling pathway
rno04060  Cytokine-cytokine receptor interaction
rno04066  HIF-1 signaling pathway
rno04110  Cell cycle
rno04115  p53 signaling pathway
rno04150  mTOR signaling pathway
rno04151  PI3K-Akt signaling pathway
rno04210  Apoptosis
rno04310  Wnt signaling pathway
rno04330  Notch signaling pathway
rno04340  Hedgehog signaling pathway
rno04350  TGF-beta signaling pathway
rno04370  VEGF signaling pathway
rno04510  Focal adhesion
rno04512  ECM-receptor interaction
rno04520  Adherens junction
rno04630  JAK-STAT signaling pathway
rno04915  Estrogen signaling pathway
KO pathway
ko05200   

DBGET integrated database retrieval system